[go: up one dir, main page]

AU2023900242A0 - Combination compositions and methods for treatment of Muscular Dystrophy - Google Patents

Combination compositions and methods for treatment of Muscular Dystrophy

Info

Publication number
AU2023900242A0
AU2023900242A0 AU2023900242A AU2023900242A AU2023900242A0 AU 2023900242 A0 AU2023900242 A0 AU 2023900242A0 AU 2023900242 A AU2023900242 A AU 2023900242A AU 2023900242 A AU2023900242 A AU 2023900242A AU 2023900242 A0 AU2023900242 A0 AU 2023900242A0
Authority
AU
Australia
Prior art keywords
treatment
methods
muscular dystrophy
combination compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023900242A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Percheron Therapeutics Ltd
Original Assignee
Antisense Therapeutics Ltd
Filing date
Publication date
Application filed by Antisense Therapeutics Ltd filed Critical Antisense Therapeutics Ltd
Publication of AU2023900242A0 publication Critical patent/AU2023900242A0/en
Priority to PCT/AU2024/050052 priority Critical patent/WO2024159266A1/en
Pending legal-status Critical Current

Links

AU2023900242A 2023-02-01 2023-02-01 Combination compositions and methods for treatment of Muscular Dystrophy Pending AU2023900242A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2024/050052 WO2024159266A1 (en) 2023-02-01 2024-01-30 Combination compositions and methods for treatment of muscular dystrophy

Publications (1)

Publication Number Publication Date
AU2023900242A0 true AU2023900242A0 (en) 2023-02-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP4121063A4 (en) Compositions and methods of treating facioscapulohumeral muscular dystrophy
EP4110369A4 (en) Methods of treatment and related compositions
EP4216961A4 (en) Compositions and methods for treatment of coronavirus infection
IL311452A (en) Compositions and methods of treating facioscapulohumeral muscular dystrophy
EP4284272A4 (en) Compositions and methods for sustained treatment of pain
EP4168425A4 (en) Methods and compositions for the treatment of muscular dystrophy
EP3946420A4 (en) Methods and compositions for treatment of coronavirus infection and associated coagulopathy
EP4121038A4 (en) Compositions and methods for the treatment of coronavirus infection and respiratory compromise
EP4138852A4 (en) Compositions and methods for the treatment of pain
AU2023900242A0 (en) Combination compositions and methods for treatment of Muscular Dystrophy
HK40095944A (en) Compositions and methods for treatment of duchenne muscular dystrophy
HK40093458A (en) Methods and compositions for the treatment of muscular dystrophy
EP4153609A4 (en) Compositions and methods for prevention of coronavirus infection
HK40110738A (en) Compositions and methods of treating facioscapulohumeral muscular dystrophy
HK40088896A (en) Compositions and methods of treating muscle dystrophy
HK40087592A (en) Compositions and methods of treating facioscapulohumeral muscular dystrophy
HK40117406A (en) Compositions and methods for treatment of pain
AU2022902622A0 (en) Methods of treatment and related compositions
HK40092897A (en) Methods and compositions for treatment and prevention of coronavirus infection
HK40119000A (en) Compositions and methods for the treatment of depression
HK40118268A (en) Compositions and methods for the treatment of depression
HK40112867A (en) Treatment of muscular dystrophy
AU2022903713A0 (en) Compositions and methods for prevention and treatment of cardiovascular disease
AU2021904069A0 (en) Compositions and methods for prevention and treatment of cardiovascular disease
AU2020900813A0 (en) Methods of treatment and related compositions